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Objective Chordal cutting targeting leaflet tethering has been described to
improve the efficacy of annuloplasty during ischemic mitral regurgitation sur-
gery. Histotripsy is a novel ultrasound based technique for tissue fragmenta-
tion through the cavitation generated at the focus of a very intense ultrasonic
pulse. We investigate the feasibility of using histotripsy for chordal cutting to
avoid cardiopulmonary bypass and invasive surgery in infarcted heart.
Methods Experiments were performed in vitro in explanted sheep heart
(N=10) and in vivo in sheep beating heart (N=5, 40±4kg). In vitro, the mitral
valve basal chordae was fixed. The ultrasound pulses were emitted from the
therapeutic device (1-MHz focused transducer) placed at a distance of 64mm.
In vivo, we performed sternotomy and the device was applied on the thorax
cavity. We analysed MV coaptation and chordae by real time 3D echocardio-
graphy before and after chordal cutting. A postmortem anatomical exploration
have been realized to confirm the section of the chordae.
Results In vitro, all the basal chordae were completely cut. The mean proce-
dure time was 6 (±3) minutes. The thickness of the chordae was the main cri-
teria affecting the duration of procedure. In the sheep, central basal chordae of
anterior leaflet were completely cut. The mean procedure time was 19 (±9) min-
utes. By echography, the sectioned chordae was visible and no mitral valve pro-
lapse was found. All the postmortem anatomical exploration of hearts confirmed
the section of the basal chordea. No additional lesions were objectified.
Conclusions Noninvasive ultrasound histotripsy succeed to cut mitral valve
basal chordae in vitro and in vivo in beating heart. Future investigation will
be needed to test this technique on its ability to decrease ischemic or func-
tional MR secondary to leaflet tethering. If positive, this will open the door of
completely noninvasive technique for MV repair especially in case of func-
tional MR.
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Background Left ventricular assist devices (LVAD) are valuable options
for mechanical circulatory support in patients with severe heart failure (HF) as
a bridge to cardiac transplantation, to recovery, or as destination therapy.
Transesophageal echocardiography (TEE) plays a key role in the management
of LVAD patients; either in guiding the device implantation or in the post-
operative hemodynamic assessment. The aim of this observational study is to
investigate the safety and usefulness of a miniaturized TEE probe designed for
continuous hemodynamic monitoring (hTEE, hemodynamic transesophageal
echocardiography; ImaCor, Garden City, NY) in hemodynamic assessment of
patients undergoing LVAD implantation.
Methods Between June 2014 and September 2014, 7 consecutive patients
underwent LVAD implantation for severe HF. hTEE probe was used for
continuous hemodynamic monitoring in the pre-, intra- and postoperative
periods. All procedures were performed by hTEE-trained physicians.
Results All data were recorded and used without need of further hemo-
dynamic device. The average number of hemodynamic assessment in each
patient was of 5.3. The average number of hemodynamic assessment leading
to therapeutic changes in each patient was 2.6. The mean duration of hTEE
probe insertion was approximately of 20 hours (9 hours, 72 hours). No device
complications were noticed during this period.
Conclusions This observation suggest that hemodynamic monitoring using
the hTEE system in LVAD patients is feasible and provides valid data after a
brief training period. The overall impact of hTEE use in these patients is yet
to be determined and further studies are still required.
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Background Aortic valve area (AVA) calculated by the continuity equation
by echocardiography (CE-TTE) is the method of reference to assess aortic
valve stenosis severity (AS). The Hakki’s formula (simplified Gorlin formula)
is another method, sometimes used during cardiac catheterization to calculate
AVA. It can also be adapted to magnetic resonance imaging (CMR) to assess
the stenotic AVA as previously demonstrated.
The aim of our study is to investigate using a large number of patients with
AS, the accuracy of the “Hakki-CMR” method to determine the severity of AS as
compared to CE-TTE and to anatomic AVA by planimetry performed by CMR.
Methods and results Between 2007 and 2014, 390 consecutive patients
with AS (mean age 81±10 years, men 55%, mean LVEF= 60±13%, underwent
clinically indicated TTE (Philips IE 33,) and CMR (Philips ACHIEVA 1.5
Tesla) within 30 days.
The mean aortic pressure gradient was 43±18 mmHg; the AVA was
0.63±0,25cm2 by CE-TTE, 0.75±0,30cm2 using Hakki-CMR and 0.65±
0,18cm2 by planimetry-CMR.
The mean differences in AVA between different methods were respectively:
1) 0.04cm2 (95% limits of agreement –0.15 to 0.21, p<0,0001) between
Hakki-CMR and CE-TTE, 2) 0.04cm2 (95% limits of agreement –0.17 to 0.23,
p=0,0002), between planimetry-CMR and the CE-TTE, 3) 0,01cm2 (95% limits
of agreement –0.16 to 0.14, p<0,0001) between Hakki-CMR and planimetry.
Conclusion In a large cohort of patients with AS, assessment of AVA using
the Hakki’s formula by CMR, yielded more reliable results than those
obtained using planimetry by CMR, and similar to those obtained using the
CE-TTE. Despite the time and cost issue of CMR, the Hakki formula used
during flow quantification, is a valuable method that is reliable easy, and fast
to apply. It may be highly useful especially in cases of suboptimal echo-
genicity by TTE and regardless of the valve’s degree of calcification.
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Purpose Chest pain is a very common cause of hospitalization in cardi-
ology departments and is associated with a large variety of cardiac disease.
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The aim of our study was to evaluate the diagnostic influence provided by a
pocket-size ultrasound (pSU) in addition to the usual evaluation (physical
examination, troponin levels, and electrocardiogram) in patients hospitalized
in cardiac unit for chest pain.
Methods Between December 2012 and December 2013, consecutive
patients referred by the emergency department were hospitalized for chest
pain in our cardiac care unit. They underwent physical examination, electro-
cardiogram, routine laboratory tests including troponin, chest X-ray and pSU.
The diagnosis of the cardiologist who admitted the patient (cardiologist was
compared to diagnosis of the cardiologist taking into account the pSU results
(cardiologist + pSU) and to the reference diagnosis at the time of hospital dis-
charge (final diagnosis).
Results Among one hundred forty one patients (91 men) included in our
study, 34 patients (24,1%) had a history of coronary artery disease (CAD).
The final diagnosis was non coronary chest pain in 80 patients (56.7%) and
chest pain from proven coronary origin in 61 patients (43.3%) (8 patients
(5.7%) with ST segment Elevation Myocardial Infarction (STEMI),
53 patients (37,6%) with Non-ST segment Elevation Myocardial Infarction
(NSTEMI)). 
Use of pSU confirmed the initial cardiologist’s diagnosis in 21%
(30 patients), corrected in only 1% (1 patient) and had no influence in 78%
(109 patients). The use of pSU did not significantly change the cardiologists
diagnosis in STEMI group and in NSTEMI group (table 1).
Conclusion In our study, use of a pocket-size ultrasound in patients
admitted in cardiac unit for chest pain did not alter significantly the initial
cardiologists diagnosis in comparison with the usual evaluation (physical
examination, troponin levels, and electrocardiogramt).
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Aims In this study, we sought to assess left ventricular (LV) function using
two-dimensional (2D) and three-dimensional (3D) speckle tracking echocar-
diography (STE) for the detection of preclinical diabetic cardiomyopathy, in
asymptomatic type 1 diabetic patients, and to evaluate evolution over a 6-year
follow-up.
Methods and results 66 asymptomatic type 1 diabetic patients with no car-
diovascular risk factors were compared to 26 matched healthy controls.
Conventional, 2D and 3D STE were performed at baseline. A subgroup of
14 patients underwent a 6-year follow-up evaluation. At baseline, diabetic
patients had similar LV ejection fraction (60 vs. 61%; p=NS), but impaired
longitudinal function, as assessed by 2D global longitudinal strain (GLS)
(–18.9±2 vs. –20.5±2; p=0.0002) and 3D GLS (–17.5±2 vs. –19±2; p=0.003).
At follow-up, diabetic patients had worsened longitudinal function compared
to baseline (2D GLS: –18.4±1 vs. –19.2±1; p=0.03). Global circumferential
(GCS) and radial (GRS) strains were unchanged at baseline and follow-up.
Metabolic status did not correlate with GLS, whereas GCS and GRS showed
a good correlation, suggestive of a compensatory increase of circumferential
and radial function in advanced stages of the disease – long-term diabetes
(GCS: –26±3 vs. –23.3±3; p= 0.008) and in the presence of microvascular
complications (GRS: 38.8±9 vs. 34.3±8; p=0.04).
Conclusion Subclinical myocardial dysfunction can be detected by 2D and
3D STE in type 1 diabetic patients, independently of any other cardiovascular
risk factors. Diabetic cardiomyopathy progression was demonstrated by a
significant echocardiographic deterioration at follow-up, but did not extend to
a clinical expression of the disease.
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Introduction Effective pulmonary arterial elastance [(Ea: end-systolic pressure
(ESP) /stroke volume (SV)] reflects a global measure of total afterload. In pulmo-
nary hypertension (PH), ESP is best approximated by pulmonary artery mean
pressure (mPAP). Along with SV, both are ideally assessed during right heart
catheterization (RHC). Novel imaging modalities, mainly phase contrast (PC)
MRI, may offer new insights in Ea estimation through non-invasive surrogates.
Purpose To test if pulmonary artery elastance can be assessed non-invasively
as the ratio of mean pulmonary artery pressure issued from trans-thoracic echo-
cardiography (TTE) to stroke volume estimated either by PC-MRI or TTE.
Methods 121 patients were evaluated for group 1 and 4 PH with multi-
modal imaging and RHC within 48 hours. mPAP was estimated using 2 val-
idated methods: the Chemla’s formula (mPAP=0.61 x sPAP + 2 mmHg),
mean tricuspid regurgitation (TR) gradient added with estimated right atrial
pressure based on inferior vena cava. Right ventricle (RV) SV was either
measured by PC MRI or extrapolated from Doppler left ventricle (LV)
output track SV.
Results There were good correlations and concordances between RHC and
non-invasive derived Ea using TTE mPAP/MRI RV SV (TR: n=96, r2=0.805,
Chemla’s formula, n=100, r2=0.807). Correlations were significant but weaker
when using TTE derived LV SV (TR: n=98, r2=0.630; Chemla’s formula:
n=102, r2=0.673).
Conclusion Ea defined as the ratio of echocardiographic mPAP (mean TR
gradient or Chemla’s formula) and PC-MRI SV correlated well with gold-
standard RHC invasive values. Added to other parameters of RV morphology
and performance, non-invasive Ea may help further estimation of right ventri-
culo-arterial coupling in PH.
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Purpose Dyspnea in the emergency department (ED) setting requires a
rapid and accurate diagnosis to start an appropriate treatment. We aimed
Abstract 125 – Table 1.
STEMI
% (95% CI)
NSTEMI
% (95% CI)
Cardiologist Cardiologist + pSU Cardiologist Cardiologist + pSU
Sensitivity 100% (63.1-100) 100% (63.1-100) 100% (93.6-100) 100% (93.6-100)
Specificity 100% (97.3-100) 100% (97.3-100) 55.3% (44.1-66.1) 56.5% (45.3-67.2)
PPV 100% (63.1-100) 100% (63.1-100) 59.6% (49.0-69.6) 60.2% (49.5-70.2)
NPV 100% (97.3-100) 100% (97.3-100) 100% (92.5-100) 100% (92.6-100)
